이명의 약물치료
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이현진 | - |
dc.date.accessioned | 2024-06-07T08:00:18Z | - |
dc.date.available | 2024-06-07T08:00:18Z | - |
dc.date.issued | 2022-12 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.issn | 2093-5951 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/74074 | - |
dc.description.abstract | Background: Tinnitus is one of the most frequent symptoms seen in otology practice. The pathogenesis of tinnitus has not yet been clearly explained, and no single hypothesis or theory is sufficient to explain the mechanisms involved in the development of this condition. Tinnitus is most commonly treated using pharmacologic methods.The aim of this study is to summarize the drugs used for the treatment of tinnitus based on previous research. Current Concepts: Pharmacologic treatment of tinnitus depends on various mechanisms. Hyperactivity of the central auditory system, neurotransmitter imbalances in auditory pathways, and blood circulation may be involved.Symptoms such as anxiety, stress, sleep disturbance, and depression are also associated with tinnitus. Various medications have been used, including anxiolytics, anticonvulsants, antidepressants, N-methyl-D-aspartate antagonists, local anesthetics, ginkgo biloba extract, other pharmacologic agents, and nutritional supplements.Discussion and Conclusion: Although pharmacologic treatments are frequently used in primary care, no medication is specifically indicated for tinnitus. Further studies are required to understand the mechanisms of tinnitus to ensure treatment safety. Appropriate medication may improve tinnitus, but efficacy is dependent upon patient comorbidities. To increase the success rate of pharmacologic treatment for tinnitus, both detailed history taking and physical examination are essential. | - |
dc.format.extent | 10 | - |
dc.language | 한국어 | - |
dc.language.iso | KOR | - |
dc.publisher | 대한의사협회 | - |
dc.title | 이명의 약물치료 | - |
dc.title.alternative | Pharmacologic treatment of tinnitus | - |
dc.type | Article | - |
dc.identifier.doi | 10.5124/jkma.2022.65.12.831 | - |
dc.identifier.bibliographicCitation | 대한의사협회지, v.65, no.12, pp 831 - 840 | - |
dc.identifier.kciid | ART002906948 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000934081900007 | - |
dc.identifier.scopusid | 2-s2.0-85152564931 | - |
dc.citation.endPage | 840 | - |
dc.citation.number | 12 | - |
dc.citation.startPage | 831 | - |
dc.citation.title | 대한의사협회지 | - |
dc.citation.volume | 65 | - |
dc.type.docType | Article | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Tinnitus | - |
dc.subject.keywordAuthor | Drug therapy | - |
dc.subject.keywordAuthor | Therapeutics | - |
dc.subject.keywordAuthor | 이명 | - |
dc.subject.keywordAuthor | 약물치료 | - |
dc.subject.keywordAuthor | 치료 | - |
dc.subject.keywordPlus | SALICYLATE-INDUCED TINNITUS | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | CLINICAL-TRIAL | - |
dc.subject.keywordPlus | GINKGO-BILOBA | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | VITAMIN-B12 | - |
dc.subject.keywordPlus | MISOPROSTOL | - |
dc.subject.keywordPlus | CAROVERINE | - |
dc.subject.keywordPlus | MEMANTINE | - |
dc.subject.keywordPlus | INJECTION | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.